RESECTABLE HEAD AND NECK SQUAMOUS CELL CARCINOMA
Clinical trials for RESECTABLE HEAD AND NECK SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RESECTABLE HEAD AND NECK SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for RESECTABLE HEAD AND NECK SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise in shrinking head and neck tumors before surgery
Disease control Recruiting nowThis study tests a drug called ivonescimab given before surgery for people with stage II to IV head and neck cancer that can be removed. The drug helps the immune system attack cancer cells. About 28 adults will take part to see if the drug shrinks tumors and is safe.
Matched conditions: RESECTABLE HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New combo therapy aims to fight stubborn head and neck cancers
Disease control Recruiting nowThis early-phase trial is for people with head and neck cancer that didn't go away or came back after treatment. Researchers are testing whether giving immunotherapy (pembrolizumab) and radiation before and during surgery can kill more cancer cells. The main goal is to find out w…
Matched conditions: RESECTABLE HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated May 06, 2026 16:03 UTC
-
Early trial aims to boost cancer treatment power
Disease control Recruiting nowThis early-stage study is testing the safety and best dose of a drug called decitabine when added to standard cancer treatments like surgery and radiation. It is for adults with a specific type of head and neck cancer not linked to HPV. The goal is to see if decitabine makes the …
Matched conditions: RESECTABLE HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 17, 2026 16:11 UTC